D. Dewailly, C. Y. Andersen, A. Balen, F. Broekmans, and N. Dilaver, The physiology and clinical utility of anti-Mü llerian hormone in women, Hum Reprod Update, vol.20, pp.370-85, 2014.

K. Jayaprakasan, S. Deb, M. Batcha, J. Hopkisson, and I. Johnson, The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mü llerian hormone and response to controlled ovarian stimulation, Fertil Steril, vol.94, pp.1775-81, 2010.

A. P. Ferraretti, L. Marca, A. Fauser, B. C. Tarlatzis, B. Nargund et al., ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum Reprod, vol.26, pp.1616-1640, 2011.

G. Nargund, B. C. Fauser, N. S. Macklon, W. Ombelet, K. Nygren et al., The ISMAAR proposal on terminology for ovarian stimulation for IVF, Hum Reprod, vol.22, pp.2801-2805, 2007.

A. Weghofer, M. Margreiter, S. Bassim, U. Sevelda, E. Beilhack et al., Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age, Fertil Steril, vol.81, pp.1002-1008, 2004.

E. M. Heijnen, M. J. Eijkemans, D. Klerk, C. Polinder, S. Beckers et al., A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial, Lancet, vol.369, pp.743-752, 2007.

A. Revelli, S. Casano, F. Salvagno, and L. Delle-piane, Milder is better? Advantages and disadvantages of ''mild'' ovarian stimulation for human in vitro fertilization, Reprod Biol Endocrinol, vol.16, pp.9-25, 2011.

O. K. Davis, IVF stimulation: protocols for poor responders, Methods Mol Biol, vol.1154, pp.329-370, 2014.

F. Ubaldi, A. Vaiarelli, D. 'anna, R. Rienzi, and L. , Management of poor responders in IVF: is there anything new?, Biomed Res Int, p.352098, 2014.

B. C. Tarlatzis and E. M. Kolibianakis, GnRH agonists vs antagonists, Best Pract Res Clin Obstet Gynaecol, vol.21, pp.57-65, 2007.

S. K. Sunkara, A. Coomarasamy, R. Faris, P. Braude, and Y. Khalaf, Long gonadotropinreleasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial, Fertil Steril, vol.101, pp.147-53, 2014.

C. Dorn, FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level?, Reprod Biomed Online, vol.11, pp.555-61, 2005.

C. Kailasam, S. D. Keay, P. Wilson, W. C. Ford, and J. M. Jenkins, Defining poor ovarian response during IVF cycles, in women aged < 40 years, and its relationship with treatment outcome, Hum Reprod, vol.19, pp.1544-1551, 2004.

M. Berkkanoglu and K. Ozgur, What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?, Fertil Steril, vol.94, pp.662-667, 2010.

E. R. Klinkert, F. J. Broekmans, C. W. Looman, J. D. Habbema, and E. R. Te-velde, Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial, Hum Reprod, vol.20, pp.611-616, 2005.

M. Youssef, Could mild/minimal ovarian stimulation-IVF displace conventional IVF in poor responder women undergoing IVF/ICSI treatment cycles: systematic review and meta-analysis, Proceedings of the 28th ESHRE Annual Meeting, vol.27, pp.302-339, 2012.

E. Confino, X. Zhang, and R. R. Kazer, GnRHa flare and IVF pregnancy rates, Int J Gynaecol Obstet, vol.85, issue.1, pp.36-45, 2004.

E. Monceau, M. P. Velez, N. Dean, and I. J. Kadoch, 450 IU versus 600 IU of gonadotropins in poor responders undergoing in vitro fertilization (IVF): preliminary report of a randomized controlled trial, Proceedings of the ASRM 68th Annual Meeting, vol.98, p.77, 2012.

J. Haas, E. Zilberberg, R. Machtinger, A. Kedem, A. Hourvitz et al., Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?, Gynecol Endocrinol, vol.31, pp.79-82, 2015.

A. Revelli, A. Chiadò, P. Dalmasso, V. Stabile, and F. Evangelista, Mild'' vs ''long'' protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial, J Assist Reprod Genet, vol.31, pp.809-824, 2014.

J. H. Yoo, S. H. Cha, C. W. Park, J. Y. Kim, and K. M. Yang, Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders, Clin Exp Reprod Med, vol.38, pp.159-63, 2011.

T. Matsaseng, T. Kruger, and W. Steyn, Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis, Gynecol Obstet Invest, vol.76, pp.233-273, 2013.

N. P. Polyzos, C. Blockeel, W. Verpoest, D. Vos, M. Stoop et al., Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria, Hum Reprod, vol.27, pp.3481-3487, 2012.

L. G. Nardo, E. Bosch, C. B. Lambalk, and T. A. Gelbaya, Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee, Hum Fertil (Camb), vol.16, pp.144-50, 2013.

W. Fan, S. Li, Q. Chen, Z. Huang, Q. Ma et al., Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis, Gynecol Endocrinol, vol.29, pp.278-84, 2013.

P. Lehert, E. M. Kolibianakis, C. A. Venetis, J. Schertz, H. Saunders et al., Recombinant human follicle stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis, Reprod Biol Endocrinol, vol.12, p.17, 2014.
DOI : 10.1186/1477-7827-12-17

URL : https://rbej.biomedcentral.com/track/pdf/10.1186/1477-7827-12-17

J. K. Bosdou, C. A. Venetis, E. M. Kolibianakis, K. A. Toulis, and D. G. Goulis, The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis, Hum Reprod Update, vol.18, pp.127-172, 2012.

N. Vlahos, M. Papalouka, O. Triantafyllidou, A. Vlachos, and P. Vakas, Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study, Reprod Biomed Online, vol.30, pp.191-197, 2015.

B. Xu, Z. Li, J. Yue, J. L. Li, and Y. , Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria, PLoS One, vol.9, p.99858, 2014.

N. Massin, I. Cedrin-durnerin, C. Coussieu, J. Galey-fontaine, J. P. Wolf et al., Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study, Hum Reprod, vol.21, pp.1204-1215, 2006.

S. L. Boulet, A. Mehta, D. M. Kissin, L. Warner, J. F. Kawwass et al., Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection, JAMA, vol.313, pp.255-63, 2015.

S. M. Nelson, L. Marca, and A. , The journey from the old to the new AMH assay: how to avoid getting lost in the values, Reprod Biomed Online, vol.23, pp.411-431, 2011.